{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:23:53Z","timestamp":1794029033717,"version":"4.8.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":207,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010661","name":"Southeastern Ontario Medical Organization","doi-asserted-by":"publisher","award":["0609"],"award-info":[{"award-number":["0609"]}],"id":[{"id":"10.13039\/501100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.101081","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:22:43Z","timestamp":1785856963000},"page":"101081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chemokine Ligand-3 (CCL3) as a Novel Mediator of Inflammatory Bowel Disease Activity"],"prefix":"10.1016","volume":"5","author":[{"given":"Eileen","family":"O\u2019Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyra","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olimpia","family":"Sienkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2974-855X","authenticated-orcid":false,"given":"Daniel J.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gastha.2026.101081_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.gastha.2026.101081_bib2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/17474124.2019.1685872","article-title":"Inflammatory bowel disease: long-term therapeutic challenges","volume":"13","author":"Ashton","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.gastha.2026.101081_bib3","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.cgh.2024.01.026","article-title":"Biomarkers for personalizing IBD therapy: the quest continues","volume":"22","author":"Atreya","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.gastha.2026.101081_bib4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/1744666X.2017.1384313","article-title":"Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3","volume":"13","author":"Schaller","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.gastha.2026.101081_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejphar.2004.07.005","article-title":"The role of CCL3\/macrophage inflammatory protein-1alpha in experimental colitis","volume":"497","author":"Ajuebor","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"10.1016\/j.gastha.2026.101081_bib6","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/MEG.0000000000001933","article-title":"Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment","volume":"32","author":"Lopetuso","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.101081_bib7","article-title":"Identification of gene signatures associated with ulcerative colitis and the association with immune infiltrates in colon cancer","volume":"14","author":"Pan","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.gastha.2026.101081_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110509","article-title":"Single-cell and bulk transcriptomics reveals M2d macrophages as a potential therapeutic strategy for mucosal healing in ulcerative colitis","volume":"121","author":"Lai","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"10.1016\/j.gastha.2026.101081_bib9","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.humpath.2012.03.008","article-title":"A histopathologic scoring system as a tool for standardized reporting of chronic (ileo)colitis and independent risk assessment for inflammatory bowel disease","volume":"43","author":"Naini","year":"2012","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.gastha.2026.101081_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/path.1245","article-title":"Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease","volume":"199","author":"Banks","year":"2003","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.gastha.2026.101081_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00054725-199606000-00004","article-title":"Chemokines in inflammatory bowel disease mucosa: expression of RANTES, macrophage inflammatory protein (MIP)-1\u03b1, MIP-1\u03b2, and \u03b3-interferon-inducible protein-10 by macrophages, lymphocytes, endothelial cells, and granulomas","volume":"2","author":"Grimm","year":"1996","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.gastha.2026.101081_bib12","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.211847","article-title":"Image co-localization - co-occurrence versus correlation","volume":"131","author":"Aaron","year":"2018","journal-title":"J Cell Sci"},{"issue":"7948","key":"10.1016\/j.gastha.2026.101081_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","article-title":"Single-cell spatial immune landscapes of primary and metastatic brain tumours","volume":"614","author":"Karimi","year":"2023","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.gastha.2026.101081_bib14","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1038\/s41596-023-00881-0","article-title":"An end-to-end workflow for multiplexed image processing and analysis","volume":"18","author":"Windhager","year":"2023","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.gastha.2026.101081_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cyto.a.24803","article-title":"OPTIMAL: an OPTimized Imaging Mass cytometry AnaLysis framework for benchmarking segmentation and data exploration","volume":"105","author":"Hunter","year":"2024","journal-title":"Cytometry A"},{"issue":"1","key":"10.1016\/j.gastha.2026.101081_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae633","article-title":"Comprehensive evaluation and practical guideline of gating methods for high-dimensional cytometry data: manual gating, unsupervised clustering, and auto-gating","volume":"26","author":"Liu","year":"2024","journal-title":"Brief Bioinform"},{"issue":"2","key":"10.1016\/j.gastha.2026.101081_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ecco-jcc\/jjad142","article-title":"Definitions of histological abnormalities in inflammatory bowel disease: an ECCO position paper","volume":"18","author":"Feakins","year":"2024","journal-title":"J Crohns Colitis"},{"issue":"8","key":"10.1016\/j.gastha.2026.101081_bib18","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/CVI.00651-12","article-title":"Macaque paneth cells express lymphoid chemokine CXCL13 and other antimicrobial peptides not previously described as expressed in intestinal crypts","volume":"20","author":"Lucero","year":"2013","journal-title":"Clin Vaccin Immunol"},{"issue":"4","key":"10.1016\/j.gastha.2026.101081_bib19","first-page":"1263","article-title":"Mucosal CCR1 gene expression as a marker of molecular activity in Crohn's disease: preliminary data","volume":"58","author":"Dobre","year":"2017","journal-title":"Rom J Morphol Embryol"},{"issue":"5","key":"10.1016\/j.gastha.2026.101081_bib20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/00365521.2017.1281435","article-title":"CCR5 expression in inflammatory bowel disease and its correlation with inflammatory cells and \u03b2-arrestin2 expression","volume":"52","author":"Ye","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101081_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112653","article-title":"Transcriptional regulation of chemokine network by biologic monotherapy in ileum of patients with Crohn's disease","volume":"147","author":"Linares","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"15","key":"10.1016\/j.gastha.2026.101081_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170733","article-title":"Macrophage-endothelial cell crosstalk orchestrates neutrophil recruitment in inflamed mucosa","volume":"133","author":"Ren","year":"2023","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.gastha.2026.101081_bib23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40744-023-00554-0","article-title":"The role of CCL3 in the pathogenesis of rheumatoid arthritis","volume":"10","author":"Yang","year":"2023","journal-title":"Rheumatol Ther"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326002025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326002025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:25:15Z","timestamp":1794025515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326002025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326002025"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101081","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemokine Ligand-3 (CCL3) as a Novel Mediator of Inflammatory Bowel Disease Activity","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101081"}}